Companies
- Companies
- Browse
Companies
SIRS-Lab produces molecular diagnostic systems to identify life-threatening infections. The main objective is early and targeted antibiotic therapy of sepsis, the leading cause of death in hospitals. More
Muti-disciplinary institute with neuroscience, cancer and cardiovascular research toghether with medicinal chemistry expertise More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2011 - 12 pages - $99
Mar 2011 - 6 pages - $500
Nov 2010 - 40 pages - $500
May 2011 - 15 pages - $125
Mar 2008 - 250 pages - $3,995
May 2011 - 15 pages - $250
May 2011 - 396 pages - $2,265
Nov 2009 - 52 pages - $3,500
May 2011 - 15 pages - $250
Sep 2010 - 25 pages - $125
Your selection
Browse By
- Therapeutic target
- Blood composition
- Blood disorders
- Blood substitute
- Blood Transfusion
- Fibrogenesis
- Hemorrhagic trauma
- Lymphatic disorders
- Sepsis
- Thrombosis
- Whole blood substitute
- Geographic location
- Albania
- Andorra
- Austria
- Belgium
- Belorussia
- Bosnia-Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Greenland
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Russia
- San Marino
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Yugoslavia
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us